The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Endometrial Hyperplasia

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Endometrial Hyperplasia


High impact information on Endometrial Hyperplasia


Chemical compound and disease context of Endometrial Hyperplasia


Biological context of Endometrial Hyperplasia


Anatomical context of Endometrial Hyperplasia


Gene context of Endometrial Hyperplasia


Analytical, diagnostic and therapeutic context of Endometrial Hyperplasia


  1. Estrogen and endometrial carcinoma. An independent pathology review supporting original risk estimate. Gordon, J., Reagan, J.W., Finkle, W.D., Ziel, H.K. N. Engl. J. Med. (1977) [Pubmed]
  2. Immunocytochemical study of progesterone receptors in hyperplastic and neoplastic endometrial tissues. Bergeron, C., Ferenczy, A., Toft, D.O., Shyamala, G. Cancer Res. (1988) [Pubmed]
  3. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. Stambolic, V., Tsao, M.S., Macpherson, D., Suzuki, A., Chapman, W.B., Mak, T.W. Cancer Res. (2000) [Pubmed]
  4. Granulosa cell tumor of the ovary. Schumer, S.T., Cannistra, S.A. J. Clin. Oncol. (2003) [Pubmed]
  5. Retinoid receptors in the human endometrium and its disorders: a possible modulator of 17 beta-hydroxysteroid dehydrogenase. Ito, K., Suzuki, T., Moriya, T., Utsunomiya, H., Sugawara, A., Konno, R., Sato, S., Sasano, H. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  6. Prevention of endometrial hyperplasia in postmenopausal women with intrauterine progesterone. Shoupe, D., Meme, D., Mezrow, G., Lobo, R.A. N. Engl. J. Med. (1991) [Pubmed]
  7. Lack of induction of endometrial hyperplasia with tamoxifen. Touraine, P., Driguez, P., Cartier, I., Yaneva, H., Kuttenn, F., Mauvais-Jarvis, P. Lancet (1995) [Pubmed]
  8. Loss of cables, a cyclin-dependent kinase regulatory protein, is associated with the development of endometrial hyperplasia and endometrial cancer. Zukerberg, L.R., DeBernardo, R.L., Kirley, S.D., D'Apuzzo, M., Lynch, M.P., Littell, R.D., Duska, L.R., Boring, L., Rueda, B.R. Cancer Res. (2004) [Pubmed]
  9. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein. Walmer, D.K., Padin, C.J., Wrona, M.A., Healy, B.E., Bentley, R.C., Tsao, M.S., Kohler, M.F., McLachlan, J.A., Gray, K.D. Cancer Res. (1995) [Pubmed]
  10. Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Sasaki, H., Nishii, H., Takahashi, H., Tada, A., Furusato, M., Terashima, Y., Siegal, G.P., Parker, S.L., Kohler, M.F., Berchuck, A. Cancer Res. (1993) [Pubmed]
  11. Genetic imbalances in precursor lesions of endometrial cancer detected by comparative genomic hybridization. Kiechle, M., Hinrichs, M., Jacobsen, A., Lüttges, J., Pfisterer, J., Kommoss, F., Arnold, N. Am. J. Pathol. (2000) [Pubmed]
  12. Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease. Steingold, K., De Ziegler, D., Cedars, M., Meldrum, D.R., Lu, J.K., Judd, H.L., Chang, R.J. J. Clin. Endocrinol. Metab. (1987) [Pubmed]
  13. The analyses of 17beta-hydroxysteroid dehydrogenase isozymes in human endometrial hyperplasia and carcinoma. Utsunomiya, H., Suzuki, T., Kaneko, C., Takeyama, J., Nakamura, J., Kimura, K., Yoshihama, M., Harada, N., Ito, K., Konno, R., Sato, S., Okamura, K., Sasano, H. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  14. Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders. Ito, K., Suzuki, T., Akahira, J., Moriya, T., Kaneko, C., Utsunomiya, H., Yaegashi, N., Okamura, K., Sasano, H. Int. J. Cancer (2002) [Pubmed]
  15. BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression. Feng, Y.Z., Shiozawa, T., Miyamoto, T., Kashima, H., Kurai, M., Suzuki, A., Konishi, I. Clin. Cancer Res. (2005) [Pubmed]
  16. K-ras mutations in endometrial carcinomas with microsatellite instability. Lagarda, H., Catasus, L., Arguelles, R., Matias-Guiu, X., Prat, J. J. Pathol. (2001) [Pubmed]
  17. Imbalance between neutral endopeptidase 24.11 and endothelin-1 expression in human endometrial carcinoma. Suzuki, T., Kikkawa, F., Ino, K., Nagasaka, T., Tamakoshi, K., Mizutani, S. Oncology (2001) [Pubmed]
  18. "Alternative" controls in a case-control study of endometrial cancer and exogenous estrogen. Hulka, B.S., Grimson, R.C., Greenberg, B.G., Kaufman, D.G., Fowler, W.C., Hogue, C.J., Berger, G.S., Pulliam, C.C. Am. J. Epidemiol. (1980) [Pubmed]
  19. DNA ploidy, cell cycle kinetics, and low versus high grade atypia in endometrial hyperplasia. Michael, H., Kotylo, P.K., Mohr, M., Roth, L.M. Am. J. Clin. Pathol. (1996) [Pubmed]
  20. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. Spicer, D.V., Ursin, G., Parisky, Y.R., Pearce, J.G., Shoupe, D., Pike, A., Pike, M.C. J. Natl. Cancer Inst. (1994) [Pubmed]
  21. Uterine-specific proteins in luminal secretions of swine leukocyte antigen-inbred miniature swine with cystic endometrial hyperplasia. Segerson, E.C., Diehl, J.R., Stuart, L.D. Biol. Reprod. (1988) [Pubmed]
  22. Anti-CD9 monoclonal antibody-stimulated invasion of endometrial cancer cell lines in vitro: possible inhibitory effect of CD9 in endometrial cancer invasion. Park, K.R., Inoue, T., Ueda, M., Hirano, T., Higuchi, T., Konishi, I., Fujiwara, H., Fujii, S. Mol. Hum. Reprod. (2000) [Pubmed]
  23. Production of activin A in hyperplasia and adenocarcinoma of the human endometrium. Otani, T., Minami, S., Yamoto, M., Umesaki, N. Gynecol. Oncol. (2001) [Pubmed]
  24. Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance. Kato, N., Watanabe, J., Jobo, T., Nishimura, Y., Fujisawa, T., Kamata, Y., Kuramoto, H. J. Cancer Res. Clin. Oncol. (2003) [Pubmed]
  25. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Maxwell, G.L., Risinger, J.I., Gumbs, C., Shaw, H., Bentley, R.C., Barrett, J.C., Berchuck, A., Futreal, P.A. Cancer Res. (1998) [Pubmed]
  26. Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma. Cassia, R., Moreno-Bueno, G., Rodríguez-Perales, S., Hardisson, D., Cigudosa, J.C., Palacios, J. J. Pathol. (2003) [Pubmed]
  27. Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. Yokoyama, Y., Charnock-Jones, D.S., Licence, D., Yanaihara, A., Hastings, J.M., Holland, C.M., Emoto, M., Sakamoto, A., Sakamoto, T., Maruyama, H., Sato, S., Mizunuma, H., Smith, S.K. Clin. Cancer Res. (2003) [Pubmed]
  28. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer. Berends, M.J., Hollema, H., Wu, Y., van Der Sluis, T., Mensink, R.G., ten Hoor, K.A., Sijmons, R.H., de Vries, E.G., Pras, E., Mourits, M.J., Hofstra, R.M., Buys, C.H., Kleibeuker, J.H., van Der Zee, A.G. Int. J. Cancer (2001) [Pubmed]
  29. Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation. Djerassi, A., Coutifaris, C., West, V.A., Asa, S.L., Kapoor, S.C., Pavlou, S.N., Snyder, P.J. J. Clin. Endocrinol. Metab. (1995) [Pubmed]
  30. Low dose transdermal estradiol/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women. Brynhildsen, J., Hammar, M. Menopause (New York, N.Y.) (2002) [Pubmed]
  31. Preclinical profiles of progestins used in formulations of oral contraceptives and hormone replacement therapy. Hammond, G.L., Rabe, T., Wagner, J.D. Am. J. Obstet. Gynecol. (2001) [Pubmed]
  32. Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone. Vereide, A.B., Arnes, M., Straume, B., Maltau, J.M., Ørbo, A. Gynecol. Oncol. (2003) [Pubmed]
  33. The value of curettage in diagnosis of endometrial hyperplasia. Xie, X., Lu, W.G., Ye, D.F., Chen, H.Z., Fu, Y.F. Gynecol. Oncol. (2002) [Pubmed]
WikiGenes - Universities